In gene-specific analyses, ApoB lowering at the CETP, NLRC5, and YIPF2 loci were significantly associated with decreased PAD risk, whereas ApoB lowering at the ANKDD1B locus was associated with increased PAD risk (Figure 4). Here, ANKDD1B is linked to peripheral arterial disease.